Thrombogenics N.V. | |
Stock Exchange | Other OTC |
EPS |
$1.18 |
Market Cap |
$192.8 M |
Shares Outstanding |
38.27 M |
Public Float |
- |
Address |
Gaston Geenslaan 1 Leuven VL 3001 Belgium |
Employees | - |
Website | http://www.oxurion.com |
Updated | 07/08/2019 |
ThromboGenics NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA (ocriplasmin) brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium. |